Dr. Friedlander received medical school training at Columbia University where he obtained his M.D. and Ph.D. degree in Biology. He remained at Columbia Presbyterian Medical Center to complete his postdoctoral training in Internal Medicine and subsequently completed a clinical fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center. He then joined the faculty of the Dana Farber Cancer Institute/Brigham and Women's Hospital as an attending physician within the Melanoma and Cutaneous Oncology Programs and as an Instructor of Medicine at Harvard Medical School. His clinical interests include the development of targeted therapies and immunotherapies for patients with melanoma, merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, basal cell carcinoma, and sebaceous gland tumors. At the Dana Farber Cancer Institute he acted as a principal investigator testing novel therapeutic approaches for melanoma including PARP inhibition, hsp90 inhibition, anti-apoptotic approaches, and immune modulatory and anti-CTLA4 based strategies. He investigated in non-melanoma skin cancers novel therapeutic strategies such as hedgehog signaling pathway inhibition in advanced basal cell carcinoma. As a member of the Division of Hematology/Medical Oncology and as the Director of the Melanoma Medical Oncology Program at Mount Sinai, he will be caring for patients with cutaneous malignancies and continue working to develop collaborative translational and basic science projects and treatments for patients with cutaneous malignancies.
In the News:
Watch Dr. Friedlander discuss a new FDA approved treatment (Erivedge) for Basal Cell Carcinoma: KTVX-TV (ABC/Salt Lake City, Utah) KRNV-TV (NBC/Reno, Nevada) WNAV-AM (Baltimore, Maryland)
Columbia-Presbyterian Medical Center, 2000, Internal Medicine
Columbia-Presbyterian Medical Center, 2002, Internal Medicine
American Board of Internal Medicine
Philip Friedlander, MD's contact info
Address & contact info:
Mount Sinai Doctors Faculty Practice
1470 Madison Avenue
New York, NY 10029 Phone: 212-241-6756
Every effort has been made to ensure the accuracy of the information in this directory. However some
changes may occur between updates. Please check with your provider to ensure that he or she
participates in your health plan.
THURSDAY, April 17, 2014 (HealthDay News) -- Doctors often recommend no treatment at all when a man is diagnosed with prostate cancer, opting instead to keep a close eye on the slow-growing tumor and acting only when it becomes aggressive.
But a new, long-term European study says this str...Full Article
MONDAY, April 14, 2014 (HealthDay News) -- A new study found that 10 percent of women with a personal or family history of breast or other cancers had at least one gene mutation that would lead their doctors to recommend changes in their routine care, including increased cancer screening.
WEDNESDAY, April 9, 2014 (HealthDay News) -- The scourge of dementia may come with a silver lining: Those with declining memory and thinking skills may be significantly less likely to die from cancer, new research indicates.
Analyzing more than 2,600 Spaniards over the age of 65, scientis...Full Article
Sharecare News posted a story about Obstetrics & Gynecology:
WEDNESDAY, April 9, 2014 (HealthDay News) -- Women with irregular menstrual cycles may have more than double the risk of ovarian cancer compared to women who have regular monthly periods, new research suggests.
This finding suggests that women with irregular periods -- including those wi...Full Article
WEDNESDAY, April 9, 2014 (HealthDay News) -- Researchers say they've discovered yet another reason to love coffee: A new study suggests that people who drink at least a cup a day have a lower risk of liver cancer compared to those who only indulge occasionally.
THURSDAY, April 3, 2014 (HealthDay News) -- A simple urine test for people with high blood pressure could help doctors determine if patients aren't taking their medication as directed or whether their body isn't respond to treatment, a new study suggests.
THURSDAY, April 3, 2014 (HealthDay News) -- For people with high blood sugar at risk of type 2 diabetes, losing weight and exercising may lessen their chances of dying from heart disease or other conditions, a new long-term study suggests.
People enrolled in the study on diabetes preventi...Full Article